A Randomized, Open-label, Single-dose, Parallel-arm, Phase 1 Study to Investigate the Pharmacokinetic Profile of a Fixed-dose Combination Tablet of Tesofensine and Metoprolol (Tesomet) and Co-administration of Tesofensine Plus Commercial Metoprolol in Adult Healthy Subjects

Trial Profile

A Randomized, Open-label, Single-dose, Parallel-arm, Phase 1 Study to Investigate the Pharmacokinetic Profile of a Fixed-dose Combination Tablet of Tesofensine and Metoprolol (Tesomet) and Co-administration of Tesofensine Plus Commercial Metoprolol in Adult Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 29 May 2018

At a glance

  • Drugs Metoprolol/tesofensine (Primary) ; Metoprolol; Tesofensine
  • Indications Prader-Willi syndrome; Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Saniona
  • Most Recent Events

    • 29 May 2018 According to a Saniona media release, positive results were announced from this trial.
    • 04 Apr 2018 Status changed to completed.
    • 07 Feb 2018 Acording to a Saniona media release, last participants have had the final visit and the obtained blood samples have been forwarded to a laboratory for analysis.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top